Evolution of Pulsed Oxygen Saturation During Interval Training Compared to Continuous Training in COPD Patients

Last updated: January 18, 2026
Sponsor: Groupe Hospitalier du Havre
Overall Status: Completed

Phase

N/A

Condition

N/A

Treatment

Interval training session

Continuous training session

Clinical Study ID

NCT05825638
2022-A02087-36
  • All Genders

Study Summary

A problem often observed during exercise training is oxygen desaturation exclusively during exercise in some patients. In the case of exercise-induced desaturation, it may be suggested to train these patients in interval training to limit exercise-induced desaturation. Interval training consists of alternating active phases of short duration (often 30 seconds to 1 minute) followed by a short active or passive recovery phase of equivalent duration to the previous phase. Investigators therefore hypothesise that interval training on a cycloergometer or treadmill can limit exercise-induced desaturation in COPD patients.

The aim of the study is to observe the evolution of pulsed oxygen saturation between a continuous training session and a interval training session.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • a diagnosis of COPD

  • participating in a pulmonary rehabilitation programme

  • with an exercise-induced desaturation less than 90%

  • no oxygen supplementation

Exclusion

Exclusion Criteria:

  • Under 18 years of age

  • Pregnant woman

  • Person not affiliated to a health insurance regime or not benefiting from a socialsecurity regime

  • Patient under curatorship, guardianship or safeguard of justice

  • Patient speaking a language other than French

  • Patient with severe hypoxaemia (SpO2 ≤ 80%) during exercise

  • Patient having had a moderate or severe exacerbation (hospitalisation forrespiratory reasons) in the previous 4 weeks

  • Patients with orthopaedic, rheumatic, vascular or neurological pathology limitingtheir ability to make an effort

  • Breastfeeding women

Study Design

Total Participants: 12
Treatment Group(s): 2
Primary Treatment: Interval training session
Phase:
Study Start date:
January 10, 2023
Estimated Completion Date:
October 10, 2025

Connect with a study center

  • Groupe Hospitalier du Havre

    Le Havre, Normandie 76290
    France

    Site Not Available

  • Groupe Hospitalier du Havre

    Le Havre 3003796, Normandy 11071621 76290
    France

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.